RecruitingNCT06809907

Kintsugi Voice Device Pivotal Study

Kintsugi Voice Device SCID-5 Pivotal Study

Sponsor

Kintsugi Mindful Wellness, Inc.

Enrollment

1,000 participants

Start Date

Mar 27, 2025

Study Type

OBSERVATIONAL

Conditions

Depression Depression Mild Depression Moderate Depression Severe

Summary

A prospective, single arm, non-randomized, pivotal clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Interview for DSM-5 (SCID-5-RV) for up to 1000 English speaking adult patients ages 22 and older living in the United States. Recruitment will occur for 1 year and participation will be for up to 2 weeks

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a voice analysis tool called the Kintsugi Voice Device to see if it can detect signs of depression or anxiety from the way a person speaks. The device uses artificial intelligence to analyze vocal patterns. **You may be eligible if...** - You are an adult willing to provide voice recordings - You may or may not have a diagnosed mental health condition (the study likely includes both groups for comparison) - You are comfortable using a digital device to record your voice **You may NOT be eligible if...** - You have conditions that significantly affect your voice (such as laryngeal surgery) - You are unable to provide informed consent - You do not meet the study's language requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEKintsugi Voice Device

The Kintsugi Voice Device is intended to be used to screen for the presence of voice signals consistent with a current moderate to severe depressive episode in patients aged 22 and older. The device is intended to be used by care providers licensed to screen for depression and in settings where the screening for depression occurs. The device is neither to be used in lieu of a complete patient evaluation nor to supplant any of the clinician's standard assessments for the screening or diagnosis of depression. The Kintsugi Voice Device is comprised of a software API and machine learning model that utilizes recorded voice samples as inputs and outputs the detection of signals consistent with current moderate to severe depressive episode as outputs.